ArticleBMC complementary medicine and therapies2024

Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.

Xingyun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.